Status:

COMPLETED

RIOTC: Reducing the Impact of Ovarian Stimulation. Novel Approaches to Luteal Support in IVF-Study 2

Lead Sponsor:

Nicholas Macklon

Collaborating Sponsors:

Gedeon Richter Ltd.

Igenomix

Conditions:

IVF

Eligibility:

FEMALE

18-35 years

Phase:

PHASE2

Brief Summary

The goal of the randomised controlled study (RCT) is to identify novel strategies that can improve the luteal phase endocrinology after ovarian stimulation, with the aim of using less or no luteal sup...

Detailed Description

The high estradiol levels generated in IVF by multiple dominant follicles at the follicular-luteal phase transition generate powerful negative feedback at the pituitary gland, effectively switching of...

Eligibility Criteria

Inclusion

  • Meet the clinical criteria for acceptance as oocyte donors (healthy women who volunteers to donate oocytes to other women).
  • Regular ovulatory cycle of 26-32 days.
  • Age: 18-35 years old.
  • Written consent.

Exclusion

  • Contraindications for ovarian stimulation or aspiration of oocytes according to local guidelines
  • Polycystic Ovary Syndrome (PCOS)
  • Allergy towards study drug
  • Women who have had a hormone or copper intra-uterine device (IUD) within 3 months
  • Exclusion of patients after earlier inclusion in the study in case of
  • Patient withdrawal of consent
  • Lack of compliance with medication
  • Medical complication arising from IVF treatment that requires the cycle to be terminated
  • Serious adverse events (SAE) or serious adverse reactions (SAR) including severe allergy to study drug.
  • Specific ARs to study drug: severe degree of hot flushed, severe degree of nausea/vomiting, severe diarrhea, severe degree of muscle and joint pain.
  • In case of exclusion of a patient after earlier inclusion in the study, a new patient will be included.

Key Trial Info

Start Date :

September 18 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 30 2020

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT04524026

Start Date

September 18 2018

End Date

November 30 2020

Last Update

January 14 2021

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Herlev Hospitals Fertilitetsklinik

Herlev, Denmark, 2730

2

Sjællands Fertilitetsklinik

Køge, Denmark, 4600